Italian Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals

Results

0 new

High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.

2 companies

Philogen

Market Cap: €938.2m

A biotechnology company, develops drugs for oncology and chronic inflammatory diseases in Switzerland and the European Union.

PHIL

€23.30

-0.4%

25.3%

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €240.6m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

€9.84

5.4%

26.2%